| CHKP quote reference | $127.13 at the July 31, 2026 close, down about 0.86% on the day | StockAnalysis.com real-time quote | August 3, 2026 |
| Market capitalization | $12.98 billion, computed as $127.13 x 102.10 million shares outstanding with 0.00% deviation | StockAnalysis.com quote and share statistics, financial_rigor.py | August 3, 2026 |
| Shares outstanding | 102.10 million, down about 4.38% year over year; about 24.48% insider and 76.56% institutional ownership | StockAnalysis.com share statistics | August 3, 2026 |
| Q2 2026 total revenues | $674 million, up 1% year over year | Check Point Q2 2026 earnings release | July 30, 2026 |
| Q2 2026 security subscriptions | $333 million, up 12% year over year | Check Point Q2 2026 earnings release | July 30, 2026 |
| Q2 2026 product revenue | Product revenues declined 14% year over year, mainly from go-to-market disruption and lower firewall appliance demand | Check Point Q2 2026 earnings call | July 30, 2026 |
| Q2 2026 EPS and profitability | GAAP EPS $1.87 up 2%, non-GAAP EPS $2.55 up 8%, GAAP operating income $185 million at 27% of revenues, non-GAAP operating income $260 million at 39% | Check Point Q2 2026 earnings release | July 30, 2026 |
| Q2 2026 cash flow | Cash flow from operations $170 million at 25% of revenues, adjusted free cash flow $161 million at 24%, including about $14 million of currency hedging benefit | Check Point Q2 2026 earnings release | July 30, 2026 |
| RPO and billings | RPO grew 7% to about $2.55 to $2.6 billion, current RPO near $1.6 billion up 4%, calculated billings near $639 million similar to last year, deferred revenue up 7% to $2.025 billion | Check Point Q2 2026 earnings release and earnings call | July 30, 2026 |
| Q2 2026 emerging technology demand | Email security, CTEM, and AI security grew more than 40% in ARR year over year, with calculated billings from these products up 35% year over year | Check Point Q2 2026 earnings call | July 30, 2026 |
| Q3 2026 guidance | Total revenue $655 to $685 million, subscription revenue $332 to $343 million, non-GAAP EPS $2.43 to $2.53 with GAAP EPS about $0.70 less, adjusted free cash flow $235 to $265 million | Check Point Q2 2026 earnings call | July 30, 2026 |
| FY2026 guidance | Management maintained the full-year 2026 guidance given in May, expects Q3 to be the trough, and expects product revenue to return to growth in Q4 | Check Point Q2 2026 earnings call | July 30, 2026 |
| Cash balances | $4,203 million of cash, marketable securities, and short-term deposits as of June 30, 2026, up from $2,913 million a year earlier, with the increase primarily from about $1.8 billion of net proceeds from the $2 billion convertible senior notes offering | Check Point Q2 2026 earnings release | July 30, 2026 |
| Balance sheet via StockAnalysis.com | Cash and cash equivalents near $2.28 billion, total debt near $1.97 billion, net cash near $2.23 billion at $21.83 per share on the statistics page, with the financials page showing a narrower net cash near $0.30 billion; this page uses the $4.2 billion earnings release figure as primary | StockAnalysis.com statistics and balance sheet | August 3, 2026 |
| Share repurchase program | About 2.5 million shares repurchased for about $325 million in Q2 2026 at an average price near $131, and the board authorized a $2 billion expansion of the ongoing repurchase program on May 11, 2026 | Check Point Q2 2026 earnings release | July 30, 2026 |
| Israel R&D grants | A $28 million reduction in research and development expenses in Q2 2026 under Israel new R&D tax incentive program enacted March 30, 2026 | Check Point Q2 2026 earnings release | July 30, 2026 |
| AI product news | Check Point launched the AI Network Firewall as part of the AI Defense Plane, positioned as the first to deliver AI security from the physical firewall, and is partnering with NVIDIA to embed firewall capability at the GPU level with impact expected around 2027 | Check Point Q2 2026 earnings call and PRNewswire | July 30, 2026 |
| FY2025 results for trend | FY2025 revenue $2.725 billion up 6.25%, net income about $1.057 billion, GAAP EPS $9.62, non-GAAP EPS $11.89 including a tax-related benefit, and free cash flow about $1.173 billion | StockAnalysis.com financials and Check Point FY2025 earnings release | August 3, 2026 |
| TTM financials | TTM revenue about $2.76 billion up 4.6%, TTM net income about $1.05 billion, TTM EPS about $9.82, TTM free cash flow about $1.10 billion | StockAnalysis.com statistics and financials | August 3, 2026 |
| Valuation ratios | Trailing PE 12.95x, forward PE 11.78x, PS 4.70x, PB 4.78x, P/FCF 11.76x, EV/EBITDA 12.16x, EV/FCF 9.74x, free cash flow yield 8.50%, earnings yield 8.08% | StockAnalysis.com statistics and financial_rigor.py | August 3, 2026 |
| Analyst consensus | Buy with an average target of $146.65 across 38 analysts, median $140, low $105, and high $201 | StockAnalysis.com forecast | August 3, 2026 |
| Analyst rating mix, July 2026 | 14 Strong Buy, 1 Buy, 23 Hold, 0 Sell out of 38 analysts | StockAnalysis.com forecast recommendation trends | August 3, 2026 |
| Recent analyst target updates | Goldman Sachs cut to $150 from $168 on August 1, Roth MKM cut to $105 from $160 on July 31, JPMorgan downgraded to Neutral from Overweight at $135, TD Cowen cut to $160 from $180, Jefferies cut to $150 from $160, Barclays cut to $140 from $145, Susquehanna raised to $150 from $140, UBS raised to $135 from $130, Stifel raised to $130 from $120, BMO raised to $140 from $135 | StockAnalysis.com forecast and news feed | August 3, 2026 |
| Short interest | 5.51 million shares short, about 6.97% of shares outstanding, about 4.64 days to cover | StockAnalysis.com statistics short selling | August 3, 2026 |
| Consensus estimates | FY2026 revenue about $2.81 billion with non-GAAP EPS about $10.42, FY2027 revenue about $2.98 billion with non-GAAP EPS about $11.40, with FY2026 EPS reflecting tax normalization from the FY2025 benefit | StockAnalysis.com forecast | August 3, 2026 |
| Technical snapshot | 5-day SMA near $133.08, 20-day SMA near $133.89, 50-day SMA near $131.13, 100-day SMA near $134.04, 200-day SMA near $158.99, 14-day RSI near 44.30, 14-day ADX near 14.11, 14-day historical volatility near 51.97%, 52-week range about $112.23 to $210.66 | Barchart technical analysis and StockAnalysis.com statistics | August 3, 2026 |